$DNLI news

The latest DNLI stock news: headlines, filings, AI summaries and sentiment for $DNLI, updated around the clock.

• Denali Therapeutics Reports Q3 2026 Earnings Driven by AVLAYAH Commercial Launch Motley Fool · November 4, 2026, 15:09 UTC
• Denali Therapeutics Projects $30M-$32M Q4 Revenue for AVLAYAH Amid Hunter Syndrome Commercialization Seeking Alpha · November 4, 2026, 02:46 UTC
• Denali Therapeutics Inc. - 10-Q Filing SEC EDGAR · November 3, 2026, 21:06 UTC
• Denali Therapeutics Inc. - 8-K Filing SEC EDGAR · November 3, 2026, 21:03 UTC
• Denali Therapeutics Inc. - 8-K Filing SEC EDGAR · July 28, 2026, 10:03 UTC
• Denali Therapeutics Inc. - 8-K Filing SEC EDGAR · June 4, 2026, 10:02 UTC
• Biogen and Denali Discontinue Parkinson's Therapy BIIB122 After Mid-Stage Trial Setback Seeking Alpha · May 22, 2026, 11:01 UTC
• Denali Therapeutics Inc. - 8-K Filing SEC EDGAR · May 22, 2026, 10:01 UTC
• Hedge Fund ADAR1 Capital Management Invests $36 Million in Denali Therapeutics Following FDA Approval Yahoo Finance · May 18, 2026, 18:43 UTC
• Hedge Fund ADAR1 Capital Management Invests $36 Million in Denali Therapeutics Following FDA Approval Motley Fool · May 18, 2026, 18:23 UTC
• Denali Therapeutics Inc. - 10-Q Filing SEC EDGAR · May 7, 2026, 20:13 UTC
• Denali Therapeutics Inc. - 8-K Filing SEC EDGAR · May 7, 2026, 20:04 UTC
• Privium Fund Acquires $5.07 Million Stake in Denali Therapeutics Ahead of FDA Drug Approval Motley Fool · May 5, 2026, 20:33 UTC